INTRODUCTION: Cerebral microdialysis is a relatively new, minimally invasive technique that permits sampling and analyzing the chemical constituents of the extracellular fluid. Although mainly used as a research tool, it is also used in the neurointensive care, in combination with other monitoring methods, in patients with severe traumatic brain injury and subarachnoid hemorrhage. Its main clinical utility is the identification of markers of ischemia and cell damage with the ultimate goal of preventing any secondary insults to the brain by instituting early appropriate treatment measures. With few exceptions, all the available data on intracerebral microdialysis in humans comes from studies performed in adults. OBJECTIVE: The purpose of this report is to provide a brief review of the intracerebral microdialysis studies performed in children. CONCLUSION: Differences in trends of concentrations of structural and excitatory amino acids have been identified in children, in comparison to those observed in adults, the significance of which remains unknown at present.
INTRODUCTION: Cerebral microdialysis is a relatively new, minimally invasive technique that permits sampling and analyzing the chemical constituents of the extracellular fluid. Although mainly used as a research tool, it is also used in the neurointensive care, in combination with other monitoring methods, in patients with severe traumatic brain injury and subarachnoid hemorrhage. Its main clinical utility is the identification of markers of ischemia and cell damage with the ultimate goal of preventing any secondary insults to the brain by instituting early appropriate treatment measures. With few exceptions, all the available data on intracerebral microdialysis in humans comes from studies performed in adults. OBJECTIVE: The purpose of this report is to provide a brief review of the intracerebral microdialysis studies performed in children. CONCLUSION: Differences in trends of concentrations of structural and excitatory amino acids have been identified in children, in comparison to those observed in adults, the significance of which remains unknown at present.
Authors: Paul Vespa; Marvin Bergsneider; Nayoa Hattori; Hsiao-Ming Wu; Sung-Cheng Huang; Neil A Martin; Thomas C Glenn; David L McArthur; David A Hovda Journal: J Cereb Blood Flow Metab Date: 2005-06 Impact factor: 6.200
Authors: R Bullock; A Zauner; J J Woodward; J Myseros; S C Choi; J D Ward; A Marmarou; H F Young Journal: J Neurosurg Date: 1998-10 Impact factor: 5.115
Authors: Roman Hlatky; Alex B Valadka; J Clay Goodman; Charles F Contant; Claudia S Robertson Journal: J Neurotrauma Date: 2004-07 Impact factor: 5.269
Authors: Bo-Michael Bellander; Emmanuel Cantais; Per Enblad; Peter Hutchinson; Carl-Henrik Nordström; Claudia Robertson; Juan Sahuquillo; Martin Smith; Nino Stocchetti; Urban Ungerstedt; Andreas Unterberg; Niels Vidiendal Olsen Journal: Intensive Care Med Date: 2004-11-10 Impact factor: 17.440
Authors: Stuart H Friess; Jill Ralston; Stephanie A Eucker; Mark A Helfaer; Colin Smith; Susan S Margulies Journal: Neurosurgery Date: 2011-11 Impact factor: 4.654
Authors: Peter J Hutchinson; Ibrahim Jalloh; Adel Helmy; Keri L H Carpenter; Elham Rostami; Bo-Michael Bellander; Martyn G Boutelle; Jeff W Chen; Jan Claassen; Claire Dahyot-Fizelier; Per Enblad; Clare N Gallagher; Raimund Helbok; Lars Hillered; Peter D Le Roux; Sandra Magnoni; Halinder S Mangat; David K Menon; Carl-Henrik Nordström; Kristine H O'Phelan; Mauro Oddo; Jon Perez Barcena; Claudia Robertson; Elisabeth Ronne-Engström; Juan Sahuquillo; Martin Smith; Nino Stocchetti; Antonio Belli; T Adrian Carpenter; Jonathan P Coles; Marek Czosnyka; Nil Dizdar; J Clay Goodman; Arun K Gupta; Troels H Nielsen; Niklas Marklund; Ambroise Montcriol; Mark T O'Connell; Maria A Poca; Asita Sarrafzadeh; Richard J Shannon; Jane Skjøth-Rasmussen; Peter Smielewski; John F Stover; Ivan Timofeev; Paul Vespa; Elizabeth Zavala; Urban Ungerstedt Journal: Intensive Care Med Date: 2015-09 Impact factor: 17.440